Abdul Moiz Hafiz, MD

Abdul Moiz Hafiz, MD

Structural Heart Disease Specialist
Cardiology
Accepting new patients
Call for an appointment
217-545-8000
or
Request appointment
Languages:
English, Urdu, Kashmiri, Hindi

    About me

    Structural Heart Disease Conditions Dr. Hafiz focuses on:

    • TAVR
    • MitraClip
    • PFO closure
    • ASD closure 
    • Watchman Device

    Gender

    Male

    Additional languages spoken

    Urdu,
    Kashmiri,
    Hindi

    Education & training

    Positions
    Assistant Professor
    Cardiology, Department of Internal Medicine
    Medical School
    Government Medical College Srinagar, University of Kashmir, Jammu and Kashmir, India
    Residency
    Winthrop University Hospital, Stony Brook University School Of Medicine, Mineola, NY - Internal Medicine
    Fellowship
    Cardiovascular Medicine Fellow: Winthrop University Hospital, Stony Brook University School Of Medicine, Mineola, NY
    Cardiovascular and Research Fellow in Interventional Cardiology: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
    Advanced Structural Heart Disease Fellow: University of Massachusetts Medical School, Worcester, MA

    Specialties

    Treatments & procedures

    Patient waiting for appointment

    Appointments

    SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community. 

    Clinical locations

    Locations

    SIU Heart & Vascular Center

    747 N. Rutledge Street Springfield, IL 62702 4th Floor
    Get Directions
    Mon - Fri: 8:00 am-4:30 pm
    217-545-8000

    Hospital privileges

    • Memorial Health, Springfield IL

    Clinical trials

    Trial
    Internal Medicine

    VICTORION-2 PREVENT: A randomized double-blind, placebo-controlled, multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease

    Active not recruiting

    PURPOSE: The purpose of this clinical trial is to find out if the investigational study treatment, called inclisiran, can help prevent cardiovascular events (such as heart attacks, strokes, and cardiovascular-related deaths) in adults who already have been diagnosed with cardiovascular disease

    Contact: Emily Starkey 217-545-7616
    Trial
    Internal Medicine

    RADIANCE Continued Access Protocol (CAP): A study of the ReCor Medical Paradise System in Clinical Hypertension

    Active not recruiting
    The purpose of this clinical trial is to find out if a medical device called the Paradise Renal Denervation System can lower blood pressure in patients who have hypertension
    Contact: Emily Starkey 217-545-7511
    Trial
    Dermatology

    A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA

    Active not recruiting

    The purpose of this study is to evaluate the long-term safety, tolerability, and effectiveness of PF-06651600(Ritlecitinib) in adult and adolescent (12 years and older) participants with Alopecia Areata.

    Contact: Rebecca Coughlin 217-545-7321